Silo Pharma, Inc. — Form 8-K
Filed October 14, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 78/100
What the filing says
On October 13, 2026, Silo Pharma purchased all intellectual property and source/object code for 'Reputation Endpoints' web-based software from individual Larry King for 150,000 shares of common stock (par value $0.0001/share). The software, its algorithms, documentation, and all derivatives transfer free and clear; King receives a 12-month lockup on shares, with indemnity capped at fair market value of consideration. Assignor warrants original creation, no third-party infringement, and no harmful code.
Why this rating
Asset acquisition materially expands product portfolio for $5.3M-cap company; 150k shares dilution non-trivial; adds operating software to revenue base, but LP survival/post-close IP risk material over 12mo window.
Tradability signal
NO TRADE
No trade: positive news with only +0.0% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: +0.15% over 4 hrs, n=240). (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $1.20 ▲ 0.00% | at our read · unknown $1.20 | +10 min · unknown $1.20 ▼ 0.42% | +30 min · unknown $1.17 ▼ 2.50% | +1 hr · unknown $1.18 ▼ 1.67% | +4 hrs · unknown $1.18 ▼ 1.67% |
The stock had already moved +0.00% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.